KR100563149B1 - 3,3-디페닐-프로필아민의 신규한 유도체의 안정한 염 - Google Patents

3,3-디페닐-프로필아민의 신규한 유도체의 안정한 염 Download PDF

Info

Publication number
KR100563149B1
KR100563149B1 KR1020057018318A KR20057018318A KR100563149B1 KR 100563149 B1 KR100563149 B1 KR 100563149B1 KR 1020057018318 A KR1020057018318 A KR 1020057018318A KR 20057018318 A KR20057018318 A KR 20057018318A KR 100563149 B1 KR100563149 B1 KR 100563149B1
Authority
KR
South Korea
Prior art keywords
acid
group
formula
phenyl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
KR1020057018318A
Other languages
English (en)
Korean (ko)
Other versions
KR20050100711A (ko
Inventor
클라우스 미세
Original Assignee
쉬바르츠파르마에이지
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7929277&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR100563149(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 쉬바르츠파르마에이지 filed Critical 쉬바르츠파르마에이지
Publication of KR20050100711A publication Critical patent/KR20050100711A/ko
Application granted granted Critical
Publication of KR100563149B1 publication Critical patent/KR100563149B1/ko
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/48—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
    • C07C215/54—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/06—Anti-spasmodics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C219/28—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)
  • Luminescent Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Detergent Compositions (AREA)
KR1020057018318A 1999-11-16 2000-11-15 3,3-디페닐-프로필아민의 신규한 유도체의 안정한 염 Expired - Lifetime KR100563149B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19955190.1 1999-11-16
DE19955190A DE19955190A1 (de) 1999-11-16 1999-11-16 Stabile Salze neuartiger Derivate von 3,3-Diphenylpropylaminen

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR10-2002-7006306A Division KR100536095B1 (ko) 1999-11-16 2000-11-15 3,3-디페닐-프로필아민의 신규한 유도체의 안정한 염

Publications (2)

Publication Number Publication Date
KR20050100711A KR20050100711A (ko) 2005-10-19
KR100563149B1 true KR100563149B1 (ko) 2006-03-21

Family

ID=7929277

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020057018318A Expired - Lifetime KR100563149B1 (ko) 1999-11-16 2000-11-15 3,3-디페닐-프로필아민의 신규한 유도체의 안정한 염
KR10-2002-7006306A Expired - Fee Related KR100536095B1 (ko) 1999-11-16 2000-11-15 3,3-디페닐-프로필아민의 신규한 유도체의 안정한 염

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR10-2002-7006306A Expired - Fee Related KR100536095B1 (ko) 1999-11-16 2000-11-15 3,3-디페닐-프로필아민의 신규한 유도체의 안정한 염

Country Status (30)

Country Link
US (1) US6858650B1 (OSRAM)
EP (3) EP1230209B3 (OSRAM)
JP (6) JP4083431B2 (OSRAM)
KR (2) KR100563149B1 (OSRAM)
CN (1) CN1215045C (OSRAM)
AT (3) ATE395056T1 (OSRAM)
AU (1) AU778132B2 (OSRAM)
BR (1) BRPI0015610C1 (OSRAM)
CA (1) CA2389749C (OSRAM)
CY (2) CY1106204T1 (OSRAM)
CZ (2) CZ302497B6 (OSRAM)
DE (5) DE29923134U1 (OSRAM)
DK (3) DK1690536T3 (OSRAM)
EA (1) EA005588B1 (OSRAM)
ES (3) ES2270240T3 (OSRAM)
GE (1) GEP20084430B (OSRAM)
HK (1) HK1045148B (OSRAM)
HU (2) HU227608B1 (OSRAM)
IL (2) IL149567A0 (OSRAM)
IS (2) IS2124B (OSRAM)
MX (1) MXPA02004603A (OSRAM)
NO (2) NO323920B1 (OSRAM)
NZ (1) NZ519230A (OSRAM)
PL (1) PL201422B1 (OSRAM)
PT (3) PT1690536E (OSRAM)
SI (3) SI1230209T1 (OSRAM)
SK (3) SK288185B6 (OSRAM)
UA (2) UA73324C2 (OSRAM)
WO (1) WO2001035957A1 (OSRAM)
ZA (1) ZA200203315B (OSRAM)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0957073A1 (en) * 1998-05-12 1999-11-17 Schwarz Pharma Ag Novel derivatives of 3,3-diphenylpropylamines
DE29923134U1 (de) * 1999-11-16 2000-06-29 Schwarz Pharma Ag, 40789 Monheim Stabile Salze neuartiger Derviate von 3,3-Diphenylpropylaminen
DE10028443C1 (de) * 2000-06-14 2002-05-29 Sanol Arznei Schwarz Gmbh Verfahren zur Herstellung von 3,3-Diarylpropylaminen, (R,S)- und (R)-4-Phenyl-2-chromanon-6-carbonsäure sowie (R)-4-Phenyl-2-chromanon-carbonsäure-cinchonidinsalz und deren Verwendung zur Herstellung eines rechtsdrehenden Hydroxybenzylalkohols und von pharmazeutischen Zusammensetzungen
DE10315917A1 (de) * 2003-04-08 2004-11-18 Schwarz Pharma Ag Hochreine Basen von 3,3-Diphenylpropylaminmonoestern
DE10315878B4 (de) 2003-04-08 2009-06-04 Schwarz Pharma Ag Vorrichtung zur transdermalen Verabreichung von Fesoterodin und Verwendung
WO2005012227A2 (en) * 2003-08-05 2005-02-10 Ranbaxy Laboratories Limited Process for preparation of 2-(3-diisopropylamino-1-phenylpropyl)-4-hydroxymethyl-phenol, a metabolite of tolterodine
ES2235648B1 (es) * 2003-12-22 2006-11-01 Ragactives, S.L. Procedimiento para la obtencion de tolterodina.
US8034823B2 (en) * 2005-02-22 2011-10-11 Savvipharm Inc Method of increasing drug oral bioavailability and compositions of less toxic orotate salts
KR100647068B1 (ko) 2005-09-15 2006-11-23 하나제약 주식회사 라세믹ｎ,ｎ-디이소프로필-3-(2-히드록시-5-메틸페닐)-3-페닐프로판아민의 제조방법
DK2029567T3 (da) * 2006-05-24 2010-11-29 Pfizer Ltd Fremgangsmåde til frembringelse af benzopyran-2-ol-derivater
AU2007267371B2 (en) * 2006-05-31 2012-09-20 Schwarz Pharma Ltd. New synthesis of substituted hydroxymethyl phenols
EP1862449A1 (en) * 2006-05-31 2007-12-05 Schwarz Pharma Ltd. A shortened synthesis of substituted hydroxymethyl phenols
IES20060424A2 (en) * 2006-06-08 2007-10-31 Schwarz Pharma Ltd Accelerated synthesis of (3-Diisopropylamino-1-phenylpropyl)-4-(hydroxymethyl)phenol and its phenolic monoesters
DE602007008389D1 (de) * 2006-06-09 2010-09-23 Schwarz Pharma Ltd Synthese von phenolischen estern von hydroxymethylphenolen
US7807715B2 (en) 2006-06-09 2010-10-05 Ucb Pharma Gmbh Pharmaceutical compositions comprising fesoterodine
BRPI0712865B1 (pt) * 2006-06-09 2021-08-17 Schwarz Pharma Ag Composição farmacêutica estabilizada compreendendo fesoterodina, método para preparação da mesma e uso de uma substância
IES20060435A2 (en) * 2006-06-12 2007-12-12 Schwarz Pharma Ltd Shortened synthesis using paraformaldehyde or trioxane
SI2027103T1 (sl) 2006-06-12 2014-07-31 Ucb Pharma Gmbh Novi kiralni vmesni produkt, postopek za njegovo proizvodnjo in njega uporaba pri proizvodnji tolterodina, fesoterodina ali njih aktivnega metabolita
US20100217034A1 (en) * 2007-09-21 2010-08-26 Actavis Group Ptc Ehf Process for the Preparation of Fesoterodine
WO2009044278A1 (en) * 2007-10-01 2009-04-09 Actavis Group Ptc Ehf Amorphous fesoterodine fumarate
WO2009122303A2 (en) * 2008-04-04 2009-10-08 Actavis Group Ptc Ehf Novel mandelate salt of fesoterodine
WO2010010464A2 (en) * 2008-07-21 2010-01-28 Actavis Group Ptc Ehf Fesoterodine substantially free of dehydroxy impurity
IT1392082B1 (it) * 2008-12-10 2012-02-09 Chemi Spa Nuove forme solide della fesoterodina fumarato
US9085507B2 (en) 2009-05-11 2015-07-21 Ratiopharm Gmbh Desfesoterodine in the form of a tartaric acid salt
IT1394219B1 (it) 2009-05-15 2012-06-01 Chemi Spa Metodo di preparazione di fesoterodina fumarato di elevata purezza.
IT1394217B1 (it) * 2009-05-15 2012-06-01 Chemi Spa Metodo di preparazione di fesoterodina e/o fesoterodina fumarato.
WO2011029005A1 (en) 2009-09-03 2011-03-10 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Crystalline forms of fesoterodine fumarate and fesoterodine base
IT1396373B1 (it) * 2009-10-29 2012-11-19 Dipharma Francis Srl Procedimento per la preparazione di fesoterodina.
EP2316432A1 (de) 2009-10-30 2011-05-04 ratiopharm GmbH Zusammensetzung enthaltend Fesoterodin und Ballaststoffe
US20110124903A1 (en) * 2009-11-20 2011-05-26 Actavis Group Ptc Ehf Solid state forms of fesoterodine intermediates
IT1397521B1 (it) * 2009-12-21 2013-01-16 Dipharma Francis Srl Procedimento per la preparazione di fesoterodina con un basso contenuto di impurezze.
IT1397920B1 (it) * 2010-02-08 2013-02-04 Dipharma Francis Srl Forma cristallina di fesoterodina fumarato e procedimento per la sua preparazione
EP2549985A1 (en) 2010-03-22 2013-01-30 Cadila Healthcare Limited Stable pharmaceutical compositions comprising fesoterodine
US8748433B2 (en) 2010-04-30 2014-06-10 Merck Sharp & Dohme Corp. β3 adrenergic receptor agonists
WO2011141932A2 (en) 2010-05-11 2011-11-17 Intas Pharmaceuticals Limited Process for preparation of phenolic monoesters of hydroxymethyl phenols
WO2011145019A1 (en) * 2010-05-17 2011-11-24 Orchid Chemicals And Pharmaceuticals Limited Improved process for diphenylpropylamine derivatives
IT1401451B1 (it) 2010-06-10 2013-07-26 Chemi Spa Nuovo processo di preparazione di 2-idrossi-4-fenil-3,4-diidro-2h-cromen-6-il-metanolo e (r)-2-[3-(diisopropilammino)-1-fenilpropil]-4-(idrossimetil)fenolo.
WO2011158257A1 (en) 2010-06-18 2011-12-22 Panacea Biotec Ltd Preparation process of fesoterodine and intermediates
WO2012025941A2 (en) 2010-08-25 2012-03-01 Cadila Healthcare Limited Processes for the preparation of fesoterodine
IT1403094B1 (it) * 2010-12-09 2013-10-04 Dipharma Francis Srl Procedimento per la preparazione di fesoterodina o un suo sale
WO2012098560A2 (en) * 2011-01-17 2012-07-26 Msn Laboratories Limited Process for the preparation of muscarinic receptor antagonist
TWI590821B (zh) 2011-01-18 2017-07-11 輝瑞有限公司 固體分子分散液
EP2508175A1 (en) 2011-04-08 2012-10-10 LEK Pharmaceuticals d.d. Pharmaceutical composition comprising fesoterodine or a salt or a solvate thereof
EP2508173A1 (en) 2011-04-08 2012-10-10 LEK Pharmaceuticals d.d. Stabilized pharmaceutical composition comprising fesoterodine
US9422228B2 (en) 2012-05-04 2016-08-23 Crystal Pharma, S.A.U. Process for the preparation of optically pure fesoterodine derivatives
ITMI20121232A1 (it) 2012-07-16 2014-01-17 Cambrex Profarmaco Milano Srl Procedimento per la preparazione di 2-(3-n,n-diisopropilamino-1-fenilpropil)-4-idrossimetil-fenolo e suoi derivati
TR201721437A2 (tr) 2017-12-25 2019-07-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Fesoterodi̇ni̇n modi̇fi̇ye salim sağlayan formülasyonlari
CN116472262A (zh) * 2020-10-27 2023-07-21 威娜德国有限责任公司 化妆品级品质的2-甲氧基甲基-对苯二胺

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1181430A (en) * 1980-11-14 1985-01-22 Bennie J. Foster (-) - n-methyl-3-(2-methylphenox)-3-phenylpropylamine, antidepressant
IL66831A0 (en) * 1981-10-05 1982-12-31 Kefalas As Indane derivatives
SE8800207D0 (sv) * 1988-01-22 1988-01-22 Kabivitrum Ab Nya aminer, deras anvendning och framstellning
EP0445749B1 (en) * 1990-03-08 1996-07-10 Fujisawa Pharmaceutical Co., Ltd. N-Monosubstituted cyclopentenylamines, a process for their preparation and their use as medicaments
JPH0483431A (ja) * 1990-07-26 1992-03-17 Seiko Epson Corp 選択呼出受信機
SE9203318D0 (sv) 1992-11-06 1992-11-06 Kabi Pharmacia Ab Novel 3,3-diphenylpropylamines, their use and preparation
SE9701144D0 (sv) * 1997-03-27 1997-03-27 Pharmacia & Upjohn Ab Novel compounds, their use and preparation
EP0957073A1 (en) 1998-05-12 1999-11-17 Schwarz Pharma Ag Novel derivatives of 3,3-diphenylpropylamines
DE29923134U1 (de) * 1999-11-16 2000-06-29 Schwarz Pharma Ag, 40789 Monheim Stabile Salze neuartiger Derviate von 3,3-Diphenylpropylaminen

Also Published As

Publication number Publication date
BR0015610B8 (pt) 2017-10-31
IL149567A (en) 2007-08-19
AU2666701A (en) 2001-05-30
BRPI0015610B1 (pt) 2016-04-19
NZ519230A (en) 2004-11-26
BR0015610A (pt) 2002-07-30
DE29923134U1 (de) 2000-06-29
GEP20084430B (OSRAM) 2008-07-25
JP2010180242A (ja) 2010-08-19
ZA200203315B (en) 2003-09-23
AU778132B2 (en) 2004-11-18
KR20020059744A (ko) 2002-07-13
KR20050100711A (ko) 2005-10-19
NO20022314D0 (no) 2002-05-15
HUP0900587A3 (en) 2010-04-28
DE50009239D1 (de) 2005-02-17
PL201422B1 (pl) 2009-04-30
EP1690536A3 (de) 2006-08-23
IS8382A (is) 2006-03-29
NO20065380L (no) 2002-05-15
NO332637B1 (no) 2012-11-26
HUP0204034A2 (hu) 2003-03-28
EA200200511A1 (ru) 2002-10-31
EP1690536B1 (de) 2008-05-14
PT1481964E (pt) 2006-12-29
SK6572002A3 (en) 2002-12-03
SK287430B6 (sk) 2010-09-07
SK288185B6 (sk) 2014-04-02
WO2001035957A3 (de) 2001-12-27
BRPI0015610C1 (pt) 2021-05-25
HK1095736A1 (en) 2007-05-18
DE50015163D1 (de) 2008-06-26
HU227608B1 (en) 2011-09-28
KR100536095B1 (ko) 2005-12-12
JP2011148824A (ja) 2011-08-04
NO323920B1 (no) 2007-07-23
JP2003514018A (ja) 2003-04-15
ES2236032T7 (es) 2012-06-14
DK1230209T3 (da) 2005-05-30
CY1110389T1 (el) 2015-04-29
ATE395056T1 (de) 2008-05-15
NO20022314L (no) 2002-05-15
EP1481964B1 (de) 2006-08-23
HU0900587D0 (en) 2009-11-30
DE50013365D1 (de) 2006-10-05
CN1390194A (zh) 2003-01-08
IS2124B (is) 2006-07-14
DK1481964T3 (da) 2006-11-27
CY1106204T1 (el) 2011-06-08
JP5650924B2 (ja) 2015-01-07
HK1045148B (zh) 2005-05-06
JP2014111589A (ja) 2014-06-19
PL356766A1 (en) 2004-07-12
CZ302497B6 (cs) 2011-06-15
HK1067114A1 (en) 2005-04-01
EP1230209B3 (de) 2011-10-05
JP5717824B2 (ja) 2015-05-13
US6858650B1 (en) 2005-02-22
ES2270240T3 (es) 2007-04-01
IS2673B (is) 2010-09-15
HU228197B1 (en) 2013-01-28
CZ302967B6 (cs) 2012-01-25
HUP0204034A3 (en) 2004-12-28
UA77322C2 (en) 2006-11-15
CA2389749C (en) 2009-03-31
ATE286872T1 (de) 2005-01-15
SI1481964T1 (sl) 2006-12-31
SK288384B6 (sk) 2016-08-01
JP2010180243A (ja) 2010-08-19
SI1230209T1 (en) 2005-06-30
JP5290351B2 (ja) 2013-09-18
MXPA02004603A (es) 2004-09-10
DK1690536T3 (da) 2008-09-01
EP1230209A2 (de) 2002-08-14
CA2389749A1 (en) 2001-05-25
EP1481964A1 (de) 2004-12-01
EA005588B1 (ru) 2005-04-28
JP2007137895A (ja) 2007-06-07
JP4083431B2 (ja) 2008-04-30
IL149567A0 (en) 2002-11-10
SI1690536T1 (sl) 2008-08-31
ES2236032T3 (es) 2005-07-16
ES2303708T3 (es) 2008-08-16
HK1045148A1 (en) 2002-11-15
ATE337293T1 (de) 2006-09-15
PT1230209E (pt) 2005-05-31
PT1690536E (pt) 2008-07-14
WO2001035957A1 (de) 2001-05-25
UA73324C2 (uk) 2005-07-15
WO2001035957A8 (de) 2001-06-21
EP1230209B1 (de) 2005-01-12
JP5503393B2 (ja) 2014-05-28
EP1690536A2 (de) 2006-08-16
IS6351A (is) 2002-04-19
CZ20021343A3 (cs) 2002-09-11
CN1215045C (zh) 2005-08-17
DE19955190A1 (de) 2001-06-21

Similar Documents

Publication Publication Date Title
KR100563149B1 (ko) 3,3-디페닐-프로필아민의 신규한 유도체의 안정한 염
SK283663B6 (sk) Spôsob prípravy kyseliny (S)-3-(aminometyl)-5-metylhexánovej
HU226475B1 (en) Process for producing (1r,4s)- and (1s,4r)-1-amino-4-hydroxymethyl-2-cyclopentene and the new intermediates
KR100486394B1 (ko) 3,3-디페닐-프로필아민의 신규한 유도체의 안정한 염
CA2998438A1 (en) New process and intermediates for preparing sacubitril or derivatives thereof
HK1067114B (en) Stable salts of novel derivatives of 3,3-diphenylpropylamines
EP2331492A1 (fr) Procede de preparation de l'ester ethylique de l'acide 4- [trans-4-[(phenylmethyl)-amino]cyclohexyl]benzoïque et de son sel hemifumarate

Legal Events

Date Code Title Description
A107 Divisional application of patent
A201 Request for examination
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20050928

PA0201 Request for examination
PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20051108

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20060217

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20060315

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20060316

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20090311

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20100310

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20110210

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 20120222

Start annual number: 7

End annual number: 7

FPAY Annual fee payment

Payment date: 20130221

Year of fee payment: 8

PR1001 Payment of annual fee

Payment date: 20130221

Start annual number: 8

End annual number: 8

FPAY Annual fee payment

Payment date: 20140220

Year of fee payment: 9

PR1001 Payment of annual fee

Payment date: 20140220

Start annual number: 9

End annual number: 9

FPAY Annual fee payment

Payment date: 20150226

Year of fee payment: 10

PR1001 Payment of annual fee

Payment date: 20150226

Start annual number: 10

End annual number: 10

FPAY Annual fee payment

Payment date: 20160218

Year of fee payment: 11

PR1001 Payment of annual fee

Payment date: 20160218

Start annual number: 11

End annual number: 11

FPAY Annual fee payment

Payment date: 20170220

Year of fee payment: 12

PR1001 Payment of annual fee

Payment date: 20170220

Start annual number: 12

End annual number: 12

FPAY Annual fee payment

Payment date: 20180219

Year of fee payment: 13

PR1001 Payment of annual fee

Payment date: 20180219

Start annual number: 13

End annual number: 13

FPAY Annual fee payment

Payment date: 20200218

Year of fee payment: 15

PR1001 Payment of annual fee

Payment date: 20200218

Start annual number: 15

End annual number: 15

PC1801 Expiration of term

Termination date: 20210515

Termination category: Expiration of duration